WallStreetZenWallStreetZen

NASDAQ: BBIO
Bridgebio Pharma Inc Stock Ownership - Who owns Bridgebio Pharma?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Bridgebio Pharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Randal W. ScottDirector2024-03-012,500$34.00
$85.00kSell
Brian C. StephensonSecretary Treasurer CFO2024-02-1618,919$37.21
$703.98kSell
Neil KumarCEO and President2024-02-1647,922$37.21
$1.78MSell
Charles J. HomcyDirector2024-02-161,509$37.21
$56.15kSell
Hannah ValantineDirector2024-02-152,915$37.75
$110.04kSell
Hannah ValantineDirector2024-02-152,915$8.45
$24.63kBuy
Hannah ValantineDirector2024-01-162,915$8.45
$24.63kBuy
Hannah ValantineDirector2024-01-162,915$37.97
$110.68kSell
Frank McCormickDirector2023-12-26100,000$42.06
$4.21MSell
Randal W. ScottDirector2023-12-182,000$40.00
$80.00kSell

1 of 4

BBIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BBIO insiders and whales buy or sell their stock.

BBIO Shareholders

What type of owners hold Bridgebio Pharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Kkr Group Partnership LP20.99%36,900,661$923.62MInsider
Kkr Genetic Disorder LP17.67%31,060,971$777.46MInsider
Kohlberg Kravis Roberts Co LP17.67%31,060,971$777.46MInstitution
Viking Global Performance LLC15.14%26,620,991$666.32MInsider
Viking Global Investors LP14.29%25,120,991$628.78MInsider
Viking Global Investors LP14.29%25,120,991$628.78MInstitution
Vanguard Group Inc7.28%12,800,294$320.39MInstitution
Blackrock Inc5.78%10,156,773$254.22MInstitution
Neil Kumar4.48%7,871,618$197.03MInsider
Aisling Capital Management LP3.45%6,068,125$151.89MInstitution

1 of 3

BBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BBIO55.86%44.14%Net SellingNet Selling
CRSP62.44%37.56%Net BuyingNet Buying
ALPN59.43%40.57%Net Buying
NUVL70.71%29.29%Net SellingNet Selling
KRYS75.55%24.45%Net SellingNet Selling
View Top Biotech Stocks

Bridgebio Pharma Stock Ownership FAQ

Who owns Bridgebio Pharma?

Bridgebio Pharma (NASDAQ: BBIO) is owned by 94.15% institutional shareholders, 74.39% Bridgebio Pharma insiders, and 0.00% retail investors. Kkr Group Partnership LP is the largest individual Bridgebio Pharma shareholder, owning 36.90M shares representing 20.99% of the company. Kkr Group Partnership LP's Bridgebio Pharma shares are currently valued at $897.79M.

If you're new to stock investing, here's how to buy Bridgebio Pharma stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.